Salem Investment Counselors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.63K Buy
900
+150
+20% +$998 ﹤0.01% 950
2026
Q1
$4.09K Buy
+750
New +$4.21K ﹤0.01% 999
2025
Q4
Sell
-870
Closed -$6.73K 1059
2025
Q3
$6.73K Hold
870
﹤0.01% 939
2025
Q2
$7.58K Hold
870
﹤0.01% 888
2025
Q1
$6.93K Hold
870
﹤0.01% 887
2024
Q4
$7.91K Hold
870
﹤0.01% 863
2024
Q3
$7.99K Hold
870
﹤0.01% 866
2024
Q2
$8.51K Hold
870
﹤0.01% 857
2024
Q1
$13.1K Hold
870
﹤0.01% 782
2023
Q4
$18.7K Hold
870
﹤0.01% 706
2023
Q3
$16.2K Sell
870
-155
-15% -$3.62K ﹤0.01% 711
2023
Q2
$26K Hold
1,025
﹤0.01% 644
2023
Q1
$26.5K Buy
1,025
+270
+36% +$7.23K ﹤0.01% 647
2022
Q4
$17.9K Sell
755
-35
-4% -$944 ﹤0.01% 679
2022
Q3
$20K Buy
790
+400
+103% +$14K ﹤0.01% 645
2022
Q2
$13K Sell
390
-550
-59% -$23.4K ﹤0.01% 746
2022
Q1
$68K Sell
940
-20,793
-96% -$1.5M ﹤0.01% 463
2021
Q4
$2M Sell
21,733
-4,135
-16% -$494K 0.07% 136
2021
Q3
$3.28M Buy
25,868
+1,350
+6% +$197K 0.18% 100
2021
Q2
$4.08M Buy
24,518
+1,634
+7% +$265K 0.22% 90
2021
Q1
$4.16M Sell
22,884
-2,141
-9% -$497K 0.25% 82
2020
Q4
$5M Sell
25,025
-1,570
-6% -$319K 0.33% 68
2020
Q3
$5.83M Sell
26,595
-5,925
-18% -$1.25M 0.45% 54
2020
Q2
$6.21M Buy
32,520
+645
+2% +$113K 0.53% 49
2020
Q1
$4.94M Buy
31,875
+300
+1% +$34.9K 0.51% 49
2019
Q4
$2.64M Buy
+31,575
New +$2.4M 0.22% 95

Other funds holding TDOC

Salem Investment Counselors's TDOC Position: Q2 2026 in Review

Salem Investment Counselors increased its Teladoc Health (TDOC) stake by 20% in Q2 2026, buying an estimated $998 and bringing the position to 900 shares worth $7.63K. The position accounts for ﹤0.01% of the portfolio, ranked #950.

Salem Investment Counselors first reported a position in TDOC in Q4 2019 and has held it in 26 quarters since. The position peaked at $6.21M in Q2 2020. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Salem Investment Counselors held 900 shares of Teladoc Health worth $7.63K as of Q2 2026.
  • Salem Investment Counselors bought 150 Teladoc Health shares in Q2 2026, an estimated $998.
  • Teladoc Health made up ﹤0.01% of Salem Investment Counselors's portfolio in Q2 2026, its #950 holding.
  • Salem Investment Counselors first reported a position in Teladoc Health in Q4 2019 and has held it in 26 quarters since.
  • Salem Investment Counselors's Teladoc Health position peaked at $6.21M in Q2 2020.
  • 347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.